Cargando…
Anti-IL-6 Therapies for Neuromyelitis Optica Spectrum Disorders: A Systematic Review of Safety and Efficacy
BACKGROUND: Neuromyelitis Optica Spectrum Disorder (NMOSD) is a chronic autoimmune disease of the central nervous system that causes recurrent attacks of optic neuritis, myelitis, and brainstem symptoms, resulting in severe neurological disability. Preventive treatment with immunosuppressive agents...
Autores principales: | Lotan, Itay, McGowan, Richard, Levy, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8033980/ https://www.ncbi.nlm.nih.gov/pubmed/32348222 http://dx.doi.org/10.2174/1570159X18666200429010825 |
Ejemplares similares
-
Efficacy and safety of tacrolimus treatment for neuromyelitis optica spectrum disorder
por: Chen, Bo, et al.
Publicado: (2017) -
Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate
por: Ramanathan, Ramnath Santosh, et al.
Publicado: (2014) -
Neuromyelitis Optica Spectrum Disorder
por: Cazzaniga, Juliana, et al.
Publicado: (2023) -
Plasmapheresis for acute attacks in neuromyelitis optica spectrum disorders
por: Levy, Michael
Publicado: (2018) -
Neuromyelitis Optica Spectrum Disorder and Anti-MOG Syndromes
por: Lana-Peixoto, Marco A., et al.
Publicado: (2019)